Tech Company Financing Transactions

Nora Therapeutics Funding Round

Nora Therapeutics, based in Palo Alto, scored $18 million in funding from Novo Ventures, Burrill & Company and Prospect Venture Partners.

Transaction Overview

Company Name
Nora Therapeutics
Announced On
4/17/2014
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series B
Investors

Novo Ventures (Lead Investor) (Health Lukatch)

Burrill & Company (Garrett Vygantas)

Prospect Venture Partners (David Schnell)

Rho Ventures (Martin Vogelbaum)

Vivo Capital (Chen Yu)

Proceeds Purpose
We are further encouraged that enrollment in the THRIVE-IVF trial is ahead of schedule and we have already received significant investigator interest for the upcoming RESPONSE trial.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
530 Lytton Ave. 2nd Floor
Palo Alto, CA 94301
USA
Phone
(650) 479-5331
Website
www.noratherapeutics.com
Email Address
[email protected]
Overview
Nora Therapeutics is a specialty biopharmaceutical company focused on developing therapeutics to address clinical unmet needs in reproductive medicine.
Profile
Nora Therapeutics LinkedIn Company Profile
Social Media
Nora Therapeutics Company Twitter Account
Company News
Nora Therapeutics News
Facebook
Nora Therapeutics on Facebook
YouTube
Nora Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Tong
  Jeffrey Tong LinkedIn Profile  Jeffrey Tong Twitter Account  Jeffrey Tong News  Jeffrey Tong on Facebook
Chief Medical Officer
Paul Kwon
  Paul Kwon LinkedIn Profile  Paul Kwon Twitter Account  Paul Kwon News  Paul Kwon on Facebook
VP - Bus. Development
Chris McClain
  Chris McClain LinkedIn Profile  Chris McClain Twitter Account  Chris McClain News  Chris McClain on Facebook
VP - Marketing
Sandra Shpilberg
  Sandra Shpilberg LinkedIn Profile  Sandra Shpilberg Twitter Account  Sandra Shpilberg News  Sandra Shpilberg on Facebook
VP - Operations
Mark Joing
  Mark Joing LinkedIn Profile  Mark Joing Twitter Account  Mark Joing News  Mark Joing on Facebook
VP - Product Management
Vera Wolowodiuk
  Vera Wolowodiuk LinkedIn Profile  Vera Wolowodiuk Twitter Account  Vera Wolowodiuk News  Vera Wolowodiuk on Facebook
VP - R & D
Darryl Carter
  Darryl Carter LinkedIn Profile  Darryl Carter Twitter Account  Darryl Carter News  Darryl Carter on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/17/2014: JumpLinc venture capital transaction
Next: 4/17/2014: Caspida venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.